Femara prevents or suppresses the adrenal glands from producing oestrogen (which may cause the growth of some types of breast cancer) without affecting the production of other steroid hormones produced by these glands. Femara is licensed for the treatment of localised breast cancer or metastatic in women who have not menstruated. There are unlicensed uses …
Letrotume prevents or suppresses the adrenal glands from producing oestrogen (which may cause the growth of some types of breast cancer) without affecting the production of other steroid hormones produced by these glands. Letrotume is licensed for the treatment of localised breast cancer or metastatic in women who have not menstruated. There are unlicensed uses …
Letrozole prevents or suppresses the adrenal glands from producing oestrogen (which may cause the growth of some types of breast cancer) without affecting the production of other steroid hormones produced by these glands. Letrozole is licensed for the treatment of localised breast cancer or metastatic in women who have not menstruated. There are unlicensed uses …
Trexozola prevents or suppresses the adrenal glands from producing oestrogen (which may cause the growth of some types of breast cancer) without affecting the production of other steroid hormones produced by these glands. Trexozola is licensed for the treatment of localised breast cancer or metastatic in women who have not menstruated. There are unlicensed uses …
Femapent prevents or suppresses the adrenal glands from producing oestrogen (which may cause the growth of some types of breast cancer) without affecting the production of other steroid hormones produced by these glands. Femapent is licensed for the treatment of localised breast cancer or metastatic in women who have not menstruated. There are unlicensed uses …